Research at Barts Health
Combination therapy with vitamin A is safe for pancreatic cancer patients, trial shows
A treatment combining a form of vitamin A with the current standard treatment for pancreatic cancer is safe for patients, according to an early phase clinical trial led by Barts Health consultant Professor Hemant Kocher.
Immunotherapy improves survival in patients with advanced bladder cancer
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Barts Health and Queen Mary University of London.
First drug found to reduce mortality in covid-19 patients trialled at Barts Health
The steroid dexamethasone has been identified as the first drug to improve survival rates in coronavirus patients, according to a study carried out at Barts Health and Queen Mary University of London, as part of a urgent nationwide public health clinical trial.
